Literature DB >> 32712517

Maintenance of sexual activity following androgen deprivation in males.

Cassian J Duthie1, Hannah J Calich2, Charlene M Rapsey3, Erik Wibowo4.   

Abstract

Androgen deprivation therapy (ADT) is a common treatment for men with systemic prostate cancer. However, ADT leads to sexual dysfunction, causing >80 % of couples to cease sexual activity completely. Here, we use a biopsychosocial framework to review factors that may influence the ability of patients on ADT to remain sexually active. We address sexual factors prior to ADT, neurobiological factors, intermittent ADT, sex aids, exercise, sleep, partner factors, masculinity, non-penetrative intimacy, depressive symptoms, and access to counselling or patient education programs. We make suggestions for future research in order to extend our understanding in this field with the goal of improving evidence-based treatment protocols and practice. Importantly, we suggest that clinicians should discuss options for sexual intimacy after ADT with both patients and their partners, as sexual inactivity is not inevitable for most, and strategies are available for helping maintain sexual intimacy.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Androgen deprivation; Masculinity; Mounting; Prostate cancer; Sexual activity; Sexual desire

Mesh:

Substances:

Year:  2020        PMID: 32712517     DOI: 10.1016/j.critrevonc.2020.103064

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  2 in total

Review 1.  Sexual function and rehabilitation after radiation therapy for prostate cancer: a review.

Authors:  David-Dan Nguyen; Alejandro Berlin; Andrew G Matthew; Nathan Perlis; Dean S Elterman
Journal:  Int J Impot Res       Date:  2021-01-06       Impact factor: 2.896

2.  Openness to Using an External Penile Prosthesis for Maintaining Sexual Intimacy by Individuals with Erectile Dysfunction: A Cross-Sectional Study.

Authors:  Fong Fu; Cassian J Duthie; Erik Wibowo; Richard J Wassersug; Lauren M Walker
Journal:  Sex Med       Date:  2022-08-26       Impact factor: 2.523

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.